Elderly-onset neuromyelitis optica which developed after the diagnosis of prostate adenocarcinoma and relapsed after a 23-valent pneumococcal polysaccharide vaccination

Internal Medicine

Volumn 51, Issue 1, 2012, Pages 103-107

  Kitazawa, Yu ^a   Warabi, Yoko ^a   Bandoh, Mitsuaki ^a   Takahashi, Toshiyuki ^b,c   Matsubara, Shiro ^a  

^a TOKYO METROPOLITAN NEUROLOGICAL HOSPITAL   (Japan)

^b TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c Yonezawa National Hospital   (Japan)

Author keywords

Anti aquaporin 4 antibody; CD4 positive T cells; Complement; Multiple sclerosis; Neuromyelitis optica; Paraneoplastic syndrome

Indexed keywords

ANTIBODY; AQUAPORIN 4 ANTIBODY; GAMMA INTERFERON; IMMUNOGLOBULIN G; METHYLPREDNISOLONE; MYELIN BASIC PROTEIN; PNEUMOCOCCUS VACCINE; UNCLASSIFIED DRUG;

AGED; ARTICLE; BLOOD ANALYSIS; CASE REPORT; CD4 CD8 RATIO; CD4+ T LYMPHOCYTE; COMPLEMENT ACTIVATION; DRUG MEGADOSE; HICCUP; HUMAN; MALE; MYELOOPTIC NEUROPATHY; NUCLEAR MAGNETIC RESONANCE IMAGING; OPTIC NEURITIS; PARAPLEGIA; PROSTATE ADENOCARCINOMA; PROTEIN CEREBROSPINAL FLUID LEVEL; RELAPSE; VISUAL IMPAIRMENT;

ADENOCARCINOMA; AGE OF ONSET; AGED; AGED, 80 AND OVER; AQUAPORIN 4; AUTOANTIBODIES; BRAIN; CD4-POSITIVE T-LYMPHOCYTES; HUMANS; LYMPHOCYTE ACTIVATION; MAGNETIC RESONANCE IMAGING; MALE; NEUROMYELITIS OPTICA; PARANEOPLASTIC SYNDROMES, NERVOUS SYSTEM; PARANEOPLASTIC SYNDROMES, OCULAR; PNEUMOCOCCAL VACCINES; PROSTATIC NEOPLASMS; RECURRENCE;

EID: 84855244637     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.51.5636     Document Type: Article

References (19)

1. Lennon VA, Kryzer TJ, Pittock SJ, Verkman AS, Hinson SR. IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel. J Exp Med 202: 473-477, 2005.
2. Bradl M, Misu T, Takahashi T, et al. Neuromyelitis optica: pathogenicity of patient immunoglobulin in vivo. Ann Neurol 66: 630-643, 2009.
3. Saadoun S, Waters P, Bell BA, Vincent A, Verkman AS, Papadopoulos MC. Intra-cerebral injection of neuromyelitis optica immunoglobulin G and human complement produces neuromyelitis optica lesions in mice. Brain 133: 349-361, 2010.
4. Wingerchuk DM, Lennon VA, Pittock SJ, Lucchinetti CF, Weinshenker BG. Revised diagnostic criteria for neuromyelitis optica. Neurology 66: 1485-1489, 2006.
5. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 33: 1444-1452, 1983.
6. Qin Z, Blankenstein T. CD4+ T cell-mediated tumor rejection involves inhibition of angiogenesis that is dependent on IFN gamma receptor expression by nonhematopoietic cells. Immunity 12: 677-686, 2000.
7. Wuorimaa T, Kayhty H, Eskola J, Bloigu A, Leroy O, Surcel HM. Activation of cell-mediated immunity following immunization with pneumococcal conjugate or polysaccharide vaccine. Scand J Immunol 53: 422-428, 2001.
8. Udani JK, Singh BB, Barrett ML, Singh VJ. Proprietary arabinogalactan extract increases antibody response to the pneumonia vaccine: a randomized, double-blind, placebo-controlled, pilot study in healthy volunteers. Nutr J 9: 32, 2010.
9. Hazlewood MA, Kumararatne DS, Webster AD, Goodall M, Bird P, Daha M. An association between homozygous C3 deficiency and low levels of anti-pneumococcal capsular polysaccharide antibodies. Clin Exp Immunol 87: 404-409, 1992.
10. Li J, Szalai AJ, Hollingshead SK, Nahm MH, Briles DE. Antibody to the type 3 capsule facilitates immune adherence of pneumococci to erythrocytes and augments their transfer to macrophages. Infect Immun 77: 464-471, 2009.
11. Russell ND, Corvalan JR, Gallo ML, Davis CG, Pirofski L. Production of protective human antipneumococcal antibodies by transgenic mice with human immunoglobulin loci. Infect Immun 68: 1820-1826, 2000.
12. Nishiyama S, Ito T, Misu T, et al. A case of NMO seropositive for aquaporin-4 antibody more than 10 years before onset. Neurology 72: 1960-1961, 2009.
13. Ortqvist A, Hedlund J, Burman LA, et al. Randomised trial of 23- valent pneumococcal capsular polysaccharide vaccine in prevention of pneumonia in middle-aged and elderly people. Swedish Pneumococcal Vaccination Study Group. Lancet 351: 399-403, 1998.
14. Butler JC, Cetron MS. Pneumococcal drug resistance: the new "special enemy of old age". Clin Infect Dis 28: 730-735, 1999.
15. Safdar A, Rodriguez GH, Rueda AM, et al. Multiple-dose granulocyte-macrophage-colony-stimulating factor plus 23-valent polysaccharide pneumococcal vaccine in patients with chronic lymphocytic leukemia: a prospective, randomized trial of safety and immunogenicity. Cancer 113: 383-387, 2008.
16. Beyer AM, Wandinger KP, Siebert E, Zschenderlein R, Klehmet J. Neuromyelitis optica in a patient with an early onset demyelinating episode: clinical and autoantibody findings. Clin Neurol Neurosurg 109: 926-930, 2007.
17. Kulkarni V, Nadgir D, Tapiawala S, et al. Biphasic demyelination of the nervous system following anti-rabies vaccination. Neurol India 52: 106-108, 2004.
18. Pittock SJ, Lennon VA. Aquaporin-4 autoantibodies in a paraneoplastic context. Arch Neurol 65: 629-632, 2008.
19. Weinshenker BG, O'Brien PC, Petterson TM, et al. A randomized trial of plasma exchange in acute central nervous system inflammatory demyelinating disease. Ann Neurol 46: 878-886, 1999.